Eric Rowinsky
Presidente en PURPLE BIOTECH LTD .
Fortuna: 4 M $ al 30/04/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michel Vounatsos | M | 62 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 8 años |
Stelios Papadopoulos | M | 75 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 años |
Krishnan Nandabalan | M | 61 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 19 años |
Dan Paterson | M | 63 | 13 años | |
Robert Gagnon | M | 49 | 14 años | |
Gil Efron | M | 57 | 6 años | |
Kristiina Vuori | M | 56 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | 29 años |
Richard Mulligan | M | 69 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 18 años |
Ian Ying Woo | M | 51 | 6 años | |
Alexander Denner | M | 54 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 18 años |
Michael Kauffman | M | 60 |
The Johns Hopkins University School of Medicine
| 20 años |
John Johnson | M | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 años |
Caroline Dorsa | F | 64 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 años |
Lynn Schenk | F | 79 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 29 años |
Daniel Calkins | M | 37 | 6 años | |
Brian Posner | M | 62 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 años |
Stephen Sherwin | M | 75 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 años |
Jean Mariani | M | 74 | 5 años | |
Nancy L. Leaming | F | 76 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 años |
Vimal Mehta | M | 63 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 19 años |
Jean-Francois H. Geschwind | M | - |
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | 16 años |
Brian Stuglik | M | 64 | 7 años | |
Christopher Viehbacher | M | 64 | 2 años | |
Robert W. Pangia | M | 72 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 27 años |
Simcha Rock | M | 73 | 11 años | |
Xiao Qin Lu | M | 49 | 8 años | |
Xu Xin Liu | F | 40 | 3 años | |
Andrei V. Gudkov | M | 66 |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 años |
Saeed Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 14 años |
Matthew Calistri | M | - |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | - |
Olga Chernova | M | - |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 años |
Ori Hershkovitz | M | 49 | 3 años | |
Michael Weiss | M | 58 | 11 años | |
Michelle Robertson | F | 57 | 3 años | |
Jesus Mantas | M | 55 | 5 años | |
Kevin Lorenz | M | 59 | 5 años | |
Shi Dong Jiang | M | 57 | 4 años | |
Yong Qing Luo | M | 54 | 2 años | |
Michael Hencke | M | - | 12 años | |
Susan Langer | F | - | 1 años | |
Samuel Berry | M | - | 8 años | |
Lior Fhima | M | - | 2 años | |
Hoi Yam Chui | F | 57 | 1 años | |
Isaac Israel | M | 44 | 12 años | |
Ido Agmon | M | 46 | 8 años | |
Monish Patolawala | M | 54 | - | |
Maria Freire | M | 69 | 3 años | |
William Hawkins | M | 70 | 5 años | |
David Sidransky | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
The Johns Hopkins University School of Medicine
| 30 años |
Malcolm Hoenlein | M | 80 | 10 años | |
Susan Alexander | F | 67 | 21 años | |
Cathy Carew | F | - | - | |
Michael Schickler | M | 55 | 4 años | |
Dov Klein | M | 72 | 9 años | |
Yael Margolin | M | 70 | 1 años | |
Yi Fan Li | M | 55 | 4 años | |
Wendell C. Taylor | M | - | - | |
Jason Rifkin | M | 46 |
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | 11 años |
Paul Bunn | M | 79 | 3 años | |
David Gionco | M | 63 | 10 años | |
Anil Kapur | M | 54 | 2 años | |
Alexander Polinsky | M | 67 |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 años |
Hagop Youssoufian | M | 67 | 7 años | |
Geoffrey L. Berman | M | - | 8 años | |
Priya Singhal | M | 56 | 3 años | |
Suzana Nahum Zilberberg | F | 53 | 3 años | |
Kenneth Hoberman | M | 59 | 11 años | |
Nicole Murphy | F | - | 9 años | |
Ki Chul Cho | M | 46 | - | |
Jennifer Yang | M | 56 | 3 años | |
David Mitchell | M | 67 | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Jed Andrew Latkin | M | 50 | 5 años | |
Andrew Hirsch | M | 53 | 14 años | |
Mike M. Goldberg | M | 65 | 5 años | |
Robert M. Forrester | M | 60 | 8 años | |
Joseph Chiapponi | M | 55 | 6 años | |
Robyn Hunter | F | 62 | 11 años | |
Christopher M. Lindblom | M | 52 | 2 años | |
Gina Consylman | F | 52 | 7 años | |
Daniel Lynch | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 9 años |
Gordon A. Troup | M | 70 | 8 años | |
Masoud Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 13 años |
Michael Rice | M | 59 | 5 años | |
John Paul Waymack | M | 71 | 52 años | |
Michael Ehlers | M | - |
The Johns Hopkins University School of Medicine
| 7 años |
Jean-Christophe Montigny | M | - | 10 años | |
Jeffrey Hrkach | M | 58 | 8 años | |
Harlan Weisman | M | 71 | 1 años | |
Shahram Seyedin-Noor | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 7 años |
Glenn L. Cooper | M | 71 | 4 años | |
James Mullen | M | 65 | 21 años | |
William Young | M | 79 | 11 años | |
Ricardo J. Gonzalez | M | 53 | 2 años | |
Noah Beerman | M | 62 | 2 años | |
Mark Pykett | M | 60 | 4 años | |
Anton G. Gueth | M | 67 | 1 años | |
Brent L. Larson | M | 61 | 20 años | |
Bobby Sandage | M | 70 | 2 años | |
Yin Yin | F | 52 | - | |
Nir Livneh | M | 45 | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 78 | 78.00% |
Israel | 12 | 12.00% |
Alemania | 10 | 10.00% |
Islas Caimán | 9 | 9.00% |
Francia | 2 | 2.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Eric Rowinsky
- Red Personal